Benign Prostatic Hyperplasia (BPH) Drugs Market Revenue 2024 to 2034
Benign Prostatic Hyperplasia (BPH) Drugs Market Revenue 2024 to 2034
Benign Prostatic Hyperplasia (BPH) Drugs Market: Growing at 11.69% CAGR, the market will expand from USD 11.98 Bn in 2024 to USD 36.19 Bn by 2034, driven by rising aging male population and new drug developments.
Report ID: 10444
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD 11.98 Bn
Forecast Year,
USD 36.19 Bn
CAGR, 2025 -
11.69%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Benign Prostatic Hyperplasia (BPH) Drugs Market Size Analysis
Benign Prostatic Hyperplasia (BPH) Drugs Market Size By Therapy & Class 2024 to 2034 (USD )
| Therapy & Class | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Small Molecules | 3.83 | 4.30 | 4.78 | 5.33 | 5.97 | 6.66 | 7.45 | 8.34 | 9.29 | 10.35 | 11.55 |
| Biologics | 4.07 | 4.55 | 5.08 | 5.69 | 6.35 | 7.10 | 7.96 | 8.86 | 9.91 | 11.13 | 12.47 |
| Advanced Therapies | 2.16 | 2.39 | 2.69 | 3.01 | 3.32 | 3.71 | 4.13 | 4.59 | 5.15 | 5.74 | 6.39 |
| Others | 1.92 | 2.15 | 2.40 | 2.67 | 3.00 | 3.35 | 3.73 | 4.18 | 4.67 | 5.18 | 5.78 |
Benign Prostatic Hyperplasia (BPH) Drugs Market Size By Indication 2024 to 2034 (USD )
| Indication | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oncology | 4.31 | 4.83 | 5.41 | 6.04 | 6.73 | 7.52 | 8.34 | 9.35 | 10.45 | 11.67 | 13.09 |
| Cardio-Metabolic | 2.16 | 2.40 | 2.68 | 3.00 | 3.35 | 3.74 | 4.18 | 4.66 | 5.20 | 5.85 | 6.56 |
| Infectious | 1.92 | 2.14 | 2.40 | 2.67 | 2.99 | 3.34 | 3.77 | 4.17 | 4.65 | 5.19 | 5.76 |
| CNS | 1.68 | 1.87 | 2.09 | 2.34 | 2.61 | 2.92 | 3.26 | 3.66 | 4.08 | 4.54 | 5.06 |
| Others | 1.92 | 2.13 | 2.37 | 2.64 | 2.96 | 3.32 | 3.71 | 4.14 | 4.64 | 5.15 | 5.71 |
Benign Prostatic Hyperplasia (BPH) Drugs Market Size By Distribution 2024 to 2034 (USD )
| Distribution | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospital Pharmacy | 5.27 | 5.91 | 6.63 | 7.40 | 8.28 | 9.23 | 10.31 | 11.45 | 12.81 | 14.39 | 16.05 |
| Retail Pharmacy | 4.31 | 4.80 | 5.35 | 5.96 | 6.65 | 7.46 | 8.33 | 9.36 | 10.41 | 11.57 | 12.96 |
| Online/Other | 2.40 | 2.67 | 2.97 | 3.34 | 3.71 | 4.13 | 4.63 | 5.17 | 5.80 | 6.45 | 7.18 |
Benign Prostatic Hyperplasia (BPH) Drugs Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 4.79 | 5.35 | 5.97 | 6.65 | 7.42 | 8.32 | 9.31 | 10.42 | 11.69 | 13.04 | 14.55 |
| Europe | 3.36 | 3.75 | 4.20 | 4.68 | 5.21 | 5.80 | 6.47 | 7.21 | 8.00 | 8.94 | 10.03 |
| Asia Pacific | 2.88 | 3.21 | 3.58 | 4.02 | 4.50 | 5.01 | 5.59 | 6.24 | 6.97 | 7.79 | 8.68 |
| Latin America | 0.48 | 0.54 | 0.60 | 0.67 | 0.76 | 0.85 | 0.95 | 1.06 | 1.17 | 1.31 | 1.46 |
| Middle East & Africa | 0.48 | 0.54 | 0.60 | 0.67 | 0.75 | 0.84 | 0.94 | 1.05 | 1.18 | 1.32 | 1.48 |
Benign Prostatic Hyperplasia (BPH) Drugs Market
Benign Prostatic Hyperplasia (BPH) Drugs Market
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
